Cargando…
Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma
Meningiomas are primary CNS tumors that arise from the arachnoid layer of the meninges. Genomic sequencing has revealed that NF2 mutations are the most common genetic alteration seen in meningiomas. Meningiomas although usually low grade, can sometimes progress to high grade. A patient who had sever...
Autores principales: | Mathew Thomas, Vinay, Bindal, Poorva, Vredenburgh, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477501/ https://www.ncbi.nlm.nih.gov/pubmed/31043950 http://dx.doi.org/10.1159/000496984 |
Ejemplares similares
-
Idiopathic Granulomatous Mastitis-A Mystery Yet to be Unraveled: A Case Series and Review of Literature
por: Mathew Thomas, Vinay, et al.
Publicado: (2020) -
Chordoma: A Case Report and Review of Literature
por: Noor, Arish, et al.
Publicado: (2020) -
Primary Bone Lymphoma: A Case Series and Review of Literature
por: Bindal, Poorva, et al.
Publicado: (2020) -
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
por: Reardon, D A, et al.
Publicado: (2012) -
Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients
por: Nunes, Fabio P., et al.
Publicado: (2013)